论文部分内容阅读
目的:观察脑心通胶囊治疗短暂性脑缺血发作(TIA)的临床疗效。方法:将TIA159例随机分为观察组80例和对照组79例。观察组采用脑心通胶囊治疗,对照组采用阿司匹林治疗。观察期间两组除服用治疗原发病药物外,停用其他血管扩张药及血小板聚集抑制药。每1～3个月随访1次,记录TIA情况,随访12个月以上。结果:观察组总有效70例,占87.5%,其中发作停止44例,占55.0%;对照组总有效48例,占60.8%,其中发作停止16例,占20.2%。两组比较,差异非常显著(P<0.01)。结论:心通胶囊治疗TIA发作的临床疗效优于阿司匹林。
Objective: To observe the clinical effect of Naoxintong capsule in treating transient ischemic attack (TIA). Methods: TIA159 cases were randomly divided into observation group 80 cases and control group 79 cases. The observation group was treated with Naoxintong capsule, while the control group was treated with aspirin. During the observation period, the two groups except taking the treatment of primary disease drugs, disable other vasodilators and platelet aggregation inhibitors. Every 1 to 3 months follow-up 1 times, record TIA, followed up for 12 months. Results: In the observation group, the total effective rate was 70 (87.5%), of which 44 were stopped (55.0%) and 48 (60.8%) in the control group, of which 16 were stopped (20.2%). The differences between the two groups were significant (P <0.01). Conclusion: Xintong capsule is superior to aspirin in the treatment of TIA.